Kyle Mikson
Stock Analyst at Canaccord Genuity
(1.87)
# 3,234
Out of 4,984 analysts
88
Total ratings
36.11%
Success rate
-8.02%
Average return
Main Sectors:
Stocks Rated by Kyle Mikson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QSI Quantum-Si incorporated | Maintains: Hold | $1 | $1.26 | -20.63% | 4 | Sep 9, 2025 | |
| CSTL Castle Biosciences | Maintains: Buy | $37 | $21.82 | +69.57% | 5 | Sep 9, 2025 | |
| QTRX Quanterix | Downgrades: Hold | $12 → $5 | $5.26 | -4.94% | 7 | Aug 11, 2025 | |
| ILMN Illumina | Maintains: Hold | $99 → $105 | $100.87 | +4.09% | 12 | Aug 1, 2025 | |
| XGN Exagen | Maintains: Buy | $8 → $11 | $9.17 | +19.96% | 4 | Jul 30, 2025 | |
| GRAL GRAIL | Maintains: Buy | $32 → $43 | $38.32 | +12.21% | 2 | May 14, 2025 | |
| BDSX Biodesix | Maintains: Buy | $50 → $30 | $6.21 | +383.09% | 4 | May 14, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $18 → $15 | $12.86 | +16.64% | 8 | May 12, 2025 | |
| GH Guardant Health | Maintains: Buy | $60 → $65 | $57.19 | +13.66% | 7 | May 1, 2025 | |
| RGEN Repligen | Maintains: Hold | $170 → $150 | $119.39 | +25.64% | 3 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.23 | +143.90% | 8 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $180 → $195 | $175.43 | +11.16% | 8 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.07 | +180.37% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $75 | $52.38 | +43.18% | 9 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $3 → $2 | $0.62 | +220.56% | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $49 | $0.40 | +12,072.19% | 1 | Mar 30, 2021 |
Quantum-Si incorporated
Sep 9, 2025
Maintains: Hold
Price Target: $1
Current: $1.26
Upside: -20.63%
Castle Biosciences
Sep 9, 2025
Maintains: Buy
Price Target: $37
Current: $21.82
Upside: +69.57%
Quanterix
Aug 11, 2025
Downgrades: Hold
Price Target: $12 → $5
Current: $5.26
Upside: -4.94%
Illumina
Aug 1, 2025
Maintains: Hold
Price Target: $99 → $105
Current: $100.87
Upside: +4.09%
Exagen
Jul 30, 2025
Maintains: Buy
Price Target: $8 → $11
Current: $9.17
Upside: +19.96%
GRAIL
May 14, 2025
Maintains: Buy
Price Target: $32 → $43
Current: $38.32
Upside: +12.21%
Biodesix
May 14, 2025
Maintains: Buy
Price Target: $50 → $30
Current: $6.21
Upside: +383.09%
10x Genomics
May 12, 2025
Maintains: Buy
Price Target: $18 → $15
Current: $12.86
Upside: +16.64%
Guardant Health
May 1, 2025
Maintains: Buy
Price Target: $60 → $65
Current: $57.19
Upside: +13.66%
Repligen
Apr 16, 2025
Maintains: Hold
Price Target: $170 → $150
Current: $119.39
Upside: +25.64%
Apr 10, 2025
Maintains: Buy
Price Target: $3
Current: $1.23
Upside: +143.90%
Feb 28, 2025
Maintains: Buy
Price Target: $180 → $195
Current: $175.43
Upside: +11.16%
Nov 14, 2024
Maintains: Buy
Price Target: $3
Current: $1.07
Upside: +180.37%
Nov 6, 2024
Maintains: Buy
Price Target: $95 → $75
Current: $52.38
Upside: +43.18%
Aug 16, 2023
Maintains: Overweight
Price Target: $3 → $2
Current: $0.62
Upside: +220.56%
Mar 30, 2021
Initiates: Overweight
Price Target: $49
Current: $0.40
Upside: +12,072.19%